Call for an instant quote 0345 90 80 161
Open Mon to Fri 08:30 - 19:00 | Sat 09:00 - 16:00 (GMT)
Or call 0345 90 80 161
30 November 2015 08:09
Breast cancer kills around 11,500 people in the UK each year
A combination of immunotherapy and chemotherapy could provide the key to treating breast cancer patients who have become resistant to existing drugs, new research suggests.
An international team of scientists tested the dual therapy on mice and say their results were "striking".
Experts at the Breast Cancer Care charity say they hope the study will be followed by further clinical trials and pave the way for the development of better treatments.
Researchers say the fact that the mice stayed free of cancer even after being given fresh tumours suggests the combined treatment provided them with ongoing immune protection.
Breast cancer has not previously been known to respond well to immunotherapy but pairing it with targeted chemotherapy produced some startling results, the research team says.
The therapy prevented tumours in the mice from being able to protect themselves from the immune system, enabling them to be attacked by cancer-fighting immune cells.
The type of cancer used by the team is one known as Her2 positive. It affects up to a fifth of all women with breast cancer and in the majority of cases results in patients becoming resistant to the drug Herceptin and other treatments.
But research leader Dr Philipp Muller, of Switzerland's University of Basel, says the technique made the tumours highly vulnerable to antibody-based immunotherapy.
It saw the mice given a chemotherapy drug and a variety of antibodies, including some which stopped the cancers shielding themselves from the animals' immune systems.
Breast cancer should not mean an end to life's luxuries, and holidaymakers can cover themselves with the help of cancer travel insurance policies.
Breast Cancer Care's Jackie Harris describes the research as interesting and a welcome forward step.
The clinical nurse specialist says the results of the early study open up the possibility of breast cancer patients who have become resistant to current drugs being treated in an alternative way in the future.
She adds that while Her2 positive breast cancer is hard to treat, research will provide the key to more effective treatments being developed.
The new study is published in the Science Translational Medicine journal.
08 July 2019
Want to taste the real France? Experience the best French food and drink at one of these excellent foodie festivals. Perfect for food and wine lovers everywhere!
[more...]
Tired of the same old travel options? Explore the best travel experiences at one of these weird and wacky festivals from around the world.
Heading to the beach? Pack everything you need for the whole family by following this simple checklist.
05 July 2019
Heading off for some sun this summer? Protect your family's skin with these top tips to stay safe in the sun and prevent sunburn and lasting skin damage.
28 June 2019
Tired of paying over the odds for your family's summer holiday? Keep your costs down with our guide on how to get away for less...
Want to see Europe's greatest sport stars go head-to-head? Then head to Minsk! The capital of Belarus hosts this year's European Games – here's everything you need to know before travelling.
Heading to the European Games? Get more from your trip to Minsk by visiting some of these must-see attractions in the capital of Belarus.
Heading to the Austrian Grand Prix this summer? Get more out of your trip to Spielberg's iconic Red Bull Ring circuit with our guide to the local area.
07 June 2019
Thinking about going camping in France this summer but don't know where to try? Here's our quick guide to the best places to camp, whatever you're looking for.
Get hitched without a hitch! Here are our top tips on how to choose your perfect wedding location abroad, covering everything from food to legalities.
03 June 2019
Want to get into surfing but not sure where to go? Here's where you should be heading to get the best beginner waves around the world.